Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cremers, RGHM"'
Autor:
Schepens, MHJ, Des Plantes, CMPZ, Somford, DM, van Erkelens, JA, Cremers, RGHM, Vries, S, Aben, KK, Hoekstra, R, Stienen, JJC, Wijsman, BP, Busstra, M.B., van Limbeek, J
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 162(15):D2294. Bohn Stafleu van Loghum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e19c2f493229fab414cd507ee4202590
https://pure.eur.nl/en/publications/ed5b9a42-4d82-4353-9a50-fb169490aee0
https://pure.eur.nl/en/publications/ed5b9a42-4d82-4353-9a50-fb169490aee0
Autor:
Detert Oude Weme SEH; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands., Hulskotte LMG; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands. l.hulskotte@dz.nl.; Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. l.hulskotte@dz.nl., Vervenne WL; Department of Medical Oncology, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands., Cremers RGHM; Department of Urology, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands., Taxis K; Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., van Berlo-van de Laar IRF; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands., Jansman FGA; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands.; Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands., Benoist GE; Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2023 Jul; Vol. 62 (7), pp. 989-996. Date of Electronic Publication: 2023 May 10.
Autor:
Vernooij RWM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Cremers RGHM; Department of Urology, Deventer Hospital, Deventer, the Netherlands., Jansen H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands., van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands., Wijsman BP; Department of Urology, Elisabeth-TweeSteden hospital, Tilburg, the Netherlands., Busstra MB; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Wijnen EM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Pos FJ; Department of Radiotherapy, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, the Netherlands., Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., van den Berkmortel F; Department of Oncology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Hulsbergen-van de Kaa CA; Department of Pathology, Laboratory for Pathology East Netherlands, Hengelo, the Netherlands., van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands., Fütterer JJ; Department of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands>., van Oort IM; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: k.aben@iknl.nl.
Publikováno v:
Urologic oncology [Urol Oncol] 2022 Jul; Vol. 40 (7), pp. 353. Date of Electronic Publication: 2022 May 30.
Autor:
Vernooij RWM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Cremers RGHM; Department of Urology, Deventer Hospital, Deventer, the Netherlands., Jansen H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands., van Andel G; Department of Urology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands., Wijsman BP; Department of Urology, Elisabeth-TweeSteden hospital, Tilburg, the Netherlands., Busstra MB; Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Wijnen EM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Pos FJ; Department of Radiotherapy, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, the Netherlands., Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., van den Berkmortel F; Department of Oncology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Hulsbergen-van de Kaa CA; Department of Pathology, Laboratory for Pathology East Netherlands, Hengelo, the Netherlands., van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands., Fütterer JJ; Department of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands., van Oort IM; Radboud Institute for Health Sciences, Department of Urology, Radboud university medical center, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: k.aben@iknl.nl.
Publikováno v:
Urologic oncology [Urol Oncol] 2020 Sep; Vol. 38 (9), pp. 735.e17-735.e25. Date of Electronic Publication: 2020 Jul 15.